| 4-CIN | α-cyano-4-hydroxycinnamate |
| AC | adenylate cyclase |
| ACSF | artificial cerebrospinal fluid |
| AMPA | a-3-hydroxy-5-methyl-4-isoxazole propionic acid |
| ANLS | astrocyte-neuron lactate shuttle |
| CNPase | 2′,3′-cyclic-nucleotide 3′-phosphodiesterase |
| CNS | central nervous system |
| DAB | 1,4-dideoxy-1,4-imino-d-arabinitol |
| DREADDs | designer receptors exclusively activated by designer drugs |
| GF109203X | bisindolylmaleimide I |
| GFAP | glial fibrillary acidic protein |
| Iba1 | ionized calcium binding adaptor molecule-1 |
| MAP2 | microtubule associated protein-2 |
| Max | maxadilan |
| MCTs | monocarboxylate transporters |
| NMDA | N-methyl-D-aspartate |
| PAC1 | PACAP type 1 |
| PACAP | pituitary adenylate cyclase-activating polypeptide |
| PBS | phosphate buffered saline |
| PKA | protein kinase A |
| PKC | protein kinase C |
| PMA | 12-myristate 13-acetate |
| PYGB | glycogen phosphorylase |
| Rp-8-Br-cAMPS | 8-Bromoadenosine-3′,5′-cyclic monophosphorothioate, Rp-isomer |
| Sq22.536 | 9-(tetrahydrofuran-2-yl)-9h-purin-6-amine |
| VIP | vasoactive intestinal polypeptide |
| VPAC | VIP/PACAP |
| SNL | spinal nerve ligation |